ORIGINAL RESEARCH
Accepted on 27 Oct 2025
CD302 regulates the malignant phenotypes of lung adenocarcinoma as a tumor suppressor gene
- 137 views
- Frontiers in Medicine
- Precision Medicine
- Research Topics
- Advancing Precision Medicine in Lung Cancer: Integrating Genomics, Liquid Biopsy and Novel Diagnostic Tools
Advancing Precision Medicine in Lung Cancer: Integrating Genomics, Liquid Biopsy and Novel Diagnostic Tools
2,406
Total downloads
13k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 23 Jul 2025
Development of a prediction model for pulmonary nodules using circulating tumor cells combined with the uAI platform
doi 10.3389/fonc.2025.1594499
- 791 views
- 1 citation
CASE REPORT
Published on 15 Jul 2025
Enhanced response to dabrafenib plus trametinib in a patient with BRAFV600E lung cancer harboring an RNF43 variant of unknown significance: a case report
doi 10.3389/fonc.2025.1600457
- 1,510 views
CASE REPORT
Published on 20 May 2025
Ensartinib in a primary pulmonary ALK-rearranged mesenchymal neoplasm harboring a novel HMBOX1::ALK fusion: a case report and literature review
doi 10.3389/fmed.2025.1572632
- 1,090 views
ORIGINAL RESEARCH
Published on 31 Mar 2025
Survival benefit from abemaciclib in non–small cell lung cancer by Kirsten rat sarcoma–mutation gene expression subtype: retrospective analysis from the JUNIPER Trial
doi 10.3389/fonc.2025.1461530
- 2,034 views
ORIGINAL RESEARCH
Published on 07 Mar 2025
Analysis of ferritinophagy-related genes associated with the prognosis and regulatory mechanisms in non-small cell lung cancer
doi 10.3389/fmed.2025.1480169
- 1,993 views
- 1 citation
ORIGINAL RESEARCH
Published on 27 Nov 2024
Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1
doi 10.3389/fonc.2024.1473327
- 2,917 views
